We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App




Novel System Enables Lightning Fast Transport of Clinical Samples

By LabMedica International staff writers
Posted on 10 Aug 2023
Print article
Image: Tempus600 is a unique transport system that ensures one-touch handling from a blood sample (Photo courtesy of Sarstedt)
Image: Tempus600 is a unique transport system that ensures one-touch handling from a blood sample (Photo courtesy of Sarstedt)

Time plays a major role in the effective transportation of clinical samples. Traditional methods of transporting these samples, like blood, urine, and swabs, from departments to labs often prove unpredictable with high variation. Now, an innovative system with one-touch enables lightning-fast transport of small clinical samples. With blood samples comprising about 75% of the items dispatched through traditional tube systems, the novel system significantly reduces the strain on existing pneumatic tube systems.

Sarstedt (Nümbrecht, Germany) has developed the Tempus600 system to increase the efficiency of sample transportation. The system facilitates one-touch handling and point-to-point delivery, leading to a significant reduction in the total turnaround time (ToTAT) from when the test is ordered to reporting the analysis result to the concerned clinician. In addition to supporting the transition to increased ambulatory treatments in hospitals and clinics, Tempus600 also aids in the efficient treatment and quicker discharge of hospitalized patients.

The Tempus600 system features a dedicated point-to-point line of 25 mm tubes without any cross points in the system, thus eliminating the risk of samples getting blocked. Samples arrive seamlessly from the ward to the lab in mere seconds without the hassles of packing, unpacking, delays, or mix-ups. Boasting an hourly capacity of up to 1250 samples, it significantly eases the pressure on existing transport systems and frees up capacity for transporting materials in addition to small clinical samples. The Tempus600 system can be installed in a hospital or building in two weeks without causing any disruptions to a hospital’s daily operations.

With the Tempus600, hospital staff is no longer burdened with hand-delivering samples or relying on traditional systems, allowing them to channel their valuable skills where they are most needed. Nurses can dedicate more time to patient care, while lab technicians can focus on collecting and examining samples. The outcome is improved results and faster, superior treatment. With the fast and dedicated pipeline offered by Tempus600, labs function optimally, eliminating the need for remote laboratories. This improved efficiency translates to faster analyses, better patient care, and a significant reduction in bed days.

Related Links:
Sarstedt

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.